logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Institute Cancer De Lorraine - Alexis Vautrin

+33383598400
secretairessurveillance-cervicofaciale-dentaire@nancy.unicancer.fr
Source: Site record.
http://www.icl-lorraine.fr

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The Lorraine Cancer Institute (Institut de Cancérologie de Lorraine – ICL), a member of Unicancer, is a private non-profit healthcare institution (ESPIC) that provides care for all patients with suspected or confirmed cancer.Recognized as serving the public interest, it does not operate a private sector or charge fees above the standard rates.As a regional comprehensive cancer center, the ICL provides both standard and highly specialized care for patients with cancer.100% Cancer Care, 100% Expertise.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Cancer treatment center

Business Subcategory

Source: Human-provided. Cancer treatment center
Source: Trial-derived.
56Total Trials
Source: Trial-derived.
16Recruiting Trials
Source: Trial-derived.
28Active Trials
Source: Trial-derived.
21Completed Trials
Source: Trial-derived.
97Unique Conditions
Source: Trial-derived.
53Unique Sponsors

Conditions

Source: Trial-derived. Breast Cancer (7)Source: Trial-derived. Ovarian Cancer (7)Source: Trial-derived. Prostate Cancer (4)Source: Trial-derived. Colorectal Cancer (3)Source: Trial-derived. Lung Cancer (3)Source: Trial-derived. Advanced Solid Tumor (2)Source: Trial-derived. Bladder Cancer (2)Source: Trial-derived. Cervical Cancer (2)

Sponsors

Source: Trial-derived. Merck Sharp & Dohme LLC (8)Source: Trial-derived. UNICANCER (8)Source: Trial-derived. Institut de Cancérologie de Lorraine (6)Source: Trial-derived. Centre Leon Berard (4)Source: Trial-derived. Bayer (3)Source: Trial-derived. Daiichi Sankyo (3)Source: Trial-derived. Institut Bergonié (3)Source: Trial-derived. Intergroupe Francophone de Cancerologie Thoracique (3)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Amenities

Amenities Available

Source: Google. Restroom